Prostate cancer: cardiovascular risk and androgen deprivation therapy

Comment

Mina Razzak. Nat Rev Urol. 2012.

. 2012 Jan 10;9(2):61.

doi: 10.1038/nrurol.2011.229.

No abstract available

Comment on

Androgen-deprivation therapy and the risk of stroke in patients with prostate cancer.
Azoulay L, Yin H, Benayoun S, Renoux C, Boivin JF, Suissa S. Azoulay L, et al. Eur Urol. 2011 Dec;60(6):1244-50. doi: 10.1016/j.eururo.2011.08.041. Epub 2011 Aug 27. Eur Urol. 2011. PMID: 21908097
Association of androgen deprivation therapy with cardiovascular death in patients with prostate cancer: a meta-analysis of randomized trials.
Nguyen PL, Je Y, Schutz FA, Hoffman KE, Hu JC, Parekh A, Beckman JA, Choueiri TK. Nguyen PL, et al. JAMA. 2011 Dec 7;306(21):2359-66. doi: 10.1001/jama.2011.1745. JAMA. 2011. PMID: 22147380